I have certificates from two lots and an independent result on one of them.
I would like the arithmetic checked rather than the conclusion asserted.
I have deliberately not used an online calculator because I want to be able to check the result.
Can someone show the working rather than just the answer?
Answer first: the economics work and the counterparty risk is the whole problem, because a group buy concentrates money and material in one person's hands.
Ordering a single lot for the whole group is the analytical advantage: one independent submission then characterises everyone's material, which spreads the cost of testing across the participants.
| Step | Value | Note |
|---|---|---|
| Vial price, 10 mg nominal | £34.00 | As advertised |
| Nominal cost per mg | £3.40 | 34 ÷ 10 |
| Measured content | 9.2 mg | Independent content assay |
| Cost per actual mg | £3.70 | 34 ÷ 9.2 |
| Dead-space loss, 20 draws | 4 % | 80 µL of a 2 mL fill |
| Cost per delivered mg | £3.85 | 3.70 ÷ 0.96 |
| First vial, with £110 assay | £14.85 | Testing dominates a single vial |
Whoever receives the consignment is the importer of record in most jurisdictions, regardless of who paid. That is a legal position rather than an administrative one and it does not divide among contributors.
Carriage costs on international consignments scale far less than linearly with weight, which is the arithmetic basis for the saving.
Split sealed vials only. Anything else breaks the certificate and the closure together.
edited 14 Jul 2025 by tobias_maartens — added the method parameters
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemDocument who paid what and who received what, in writing, before anything ships.
Keep a written record: who contributed, what was ordered, which lot arrived, how many vials each person received and when. It resolves disputes and it is the only documentation that will exist.
The underlying point is that a first group order should be small for the same reason a first individual order should be, and the argument is stronger rather than weaker when several people are exposed.
Write down who paid what and who received what, before it ships.
Answering this needs to know whether the split is of sealed vials or of anything opened, since those are different situations entirely.
Onward distribution — even at cost, even among people who paid — may be a different legal act from personal importation in many jurisdictions. It is worth understanding the local position rather than assuming.
Splitting sealed vials preserves the manufacturer's container closure and the lot traceability. Splitting anything that has been opened, reconstituted or repackaged breaks both and no certificate follows the material after that point.
Importer-of-record status attaches to the receiving party in most customs regimes and is not divisible among contributors.
Whoever receives it is the importer. Make sure that person knows.
edited 16 May 2025 by Dr_Rosalind_Achebe — corrected a unit error in the worked example
A single lot across the group is the one genuine analytical advantage, because everyone's vial is then covered by the same test.
The real saving is in carriage and in unit price breaks, not in the compound itself. Carriage on a single larger consignment is typically a fraction of the sum of individual shipments, and that is where most of the arithmetic comes from.
The caveat is legal rather than analytical: onward supply is treated differently from personal importation in many jurisdictions and the difference is not a technicality.
Start small even with several people. Especially with several people.
The short version: real savings on carriage and unit price, real risks in custody, splitting and the legal position of whoever receives it.
Custody is the risk. One person holds the money before the order and the material after it, and there is no mechanism to compel anything if it goes wrong.
A single lot across all participants means one independent submission characterises the whole consignment, which is the strongest analytical argument for the arrangement.
Nothing here is legal or medical advice, and research-use compounds are not approved for human use.
One lot for the group means one submission covers everybody. That is the real advantage.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.